Homeostasis Model Assessment of β-Cell Function for Diagnosis of Insulinoma
The Journal of Clinical Endocrinology & Metabolism · 2024
DOI: 10.1210/clinem/dgad618 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Kálmán Bódis und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Diabetology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, 40225 Düsseldo…. Hauptthemen laut MEDLINE: Insulinoma, Pancreatic Neoplasms, Insulin Resistance. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Context
Diagnosis of insulinoma is based on different criteria from the 72-hour fasting test according to current guidelines (Endocrine Society [ES], European [ENETS], and North American [NANETS] Neuroendocrine Tumor Societies), including assessment of β-cell function by glucagon stimulation test.
Objective
This study tested whether the homeostasis model assessment of insulin secretion, including assessment of β-cell function, (HOMA-B) at the end of the fasting test provides comparable efficacy for insulinoma diagnosis.
Methods
In 104 patients with suspected insulinoma, 72-hour fasting tests were performed with frequent assessment of glucose, insulin, and C-peptide in venous blood. HOMA-B values using insulin and C-peptide were calculated at the end of the fasting test, as defined by the lowest glucose concentration from each participant.
Results
HOMA-B was more than 6.5-fold higher in patients with (n = 23) than in those without (n = 81) insulinoma (insulin and C-peptide; both P < .001). HOMA-B (cutoff using insulin >253 a.u. and C-peptide >270 a.u.) had a sensitivity of 0.96, 0.78 to 1.00, and a specificity of 0.96 or greater (≥0.89-0.99) for insulinoma diagnosis. ES and ENETS/NANETS criteria reached a diagnostic sensitivity of less than or equal to 0.96 (≤0.78-1.00) and ≤0.83 (≤0.61-0.95) as well as specificity of ≤0.85 (≤0.76-0.92) and less than or equal to 1.00 (≤0.96-1.00) for insulin, and C-peptide, respectively. Using insulin for HOMA-B, sensitivity tended to be higher compared to ENETS/NANETS criteria (P = .063) and specificity was higher compared to ES criteria using insulin and C-peptide (both P < .005).
Conclusion
HOMA-B, as calculated at the end of the fasting test employing defined cutoffs for insulin and C-peptide, provides excellent diagnostic efficacy, suggesting that it might represent an alternative and precise tool to diagnose insulinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Diabetology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.
- German Center for Diabetes Research, Partner Düsseldorf, 85764 München-Neuherberg, Germany.
- Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.
- Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.
- Department of Internal Medicine, Gastroenterology and Diabetology, Niels Stensen Hospitals, Franziskus Hospital Harderberg, 49124 Georgsmarienhütte, Germany.
ORCID-Profile: Klaus Strassburger, Volker Burkart, Michael Roden, Karsten Müssig
Zitieren
APA
Bódis, K., Schön, M., Dauben, L., Wilker, M., Strassburger, K., Burkart, V., Roden, M., & Müssig, K. (2024). Homeostasis Model Assessment of β-Cell Function for Diagnosis of Insulinoma. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad618
Vancouver
Bódis K, Schön M, Dauben L, Wilker M, Strassburger K, Burkart V, et al. Homeostasis Model Assessment of β-Cell Function for Diagnosis of Insulinoma. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgad618
BibTeX
@article{Bdis2024,
author = {Bódis, Kálmán and Schön, Martin and Dauben, Laura and Wilker, Miriam and Strassburger, Klaus and Burkart, Volker and Roden, Michael and Müssig, Karsten},
title = {Homeostasis Model Assessment of β-Cell Function for Diagnosis of Insulinoma},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2024},
doi = {10.1210/clinem/dgad618}
}
EUVIMED